CDAK NASDAQ
Codiak BioSciences, Inc.
1W: +33.3%
1M: +58.7%
3M: -96.5%
1Y: -99.4%
$0.06
Last traded 2023-05-23 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$34M
Revenue
+98.9% YoY
$-29M
Net Income
+59.3% YoY
$-68M
Free Cash Flow
+25.2% YoY
100.0%
Gross Margin
-76414.3%
Op. Margin
-61285.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-80.2%
ROA-19.9%
ROIC-86.9%
Valuation
P/E-0.0
P/B0.0
EV/EBITDA-1.0
Leverage
Debt/Equity1.57
Current Ratio4.24
Interest Cov.-19.9x
Quality Scores
Piotroski F2/9
Altman Z-3.97
Beneish M-5.19